Cartesian Growth Corporation II Warrant
Cartesian Growth Corporation II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.
Cartesian Growth Corporation II Warrant (RENEW) - Net Assets
Latest net assets as of June 2025: $64.71 Million USD
Based on the latest financial reports, Cartesian Growth Corporation II Warrant (RENEW) has net assets worth $64.71 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($87.39 Million) and total liabilities ($22.68 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $64.71 Million |
| % of Total Assets | 74.05% |
| Annual Growth Rate | 1345.01% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 491272.75 |
Cartesian Growth Corporation II Warrant - Net Assets Trend (2021–2024)
This chart illustrates how Cartesian Growth Corporation II Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cartesian Growth Corporation II Warrant (2021–2024)
The table below shows the annual net assets of Cartesian Growth Corporation II Warrant from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $64.30 Million | -58.70% |
| 2023-12-31 | $155.71 Million | -29.77% |
| 2022-12-31 | $221.71 Million | +1042102.64% |
| 2021-12-31 | $21.27K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cartesian Growth Corporation II Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2025831400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $84.57 Million | 131.51% |
| Total Equity | $64.30 Million | 100.00% |
Cartesian Growth Corporation II Warrant Competitors by Market Cap
The table below lists competitors of Cartesian Growth Corporation II Warrant ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO
|
$737.16 Million |
|
Aditya Birla Real Estate Limited
NSE:ABREL
|
$737.20 Million |
|
Global Infotech Co Ltd
SHE:300465
|
$737.41 Million |
|
Aecon Group Inc
PINK:AEGXF
|
$737.44 Million |
|
Nextdecade Corp
NASDAQ:NEXT
|
$736.56 Million |
|
Verallia Société Anonyme
PINK:VRLAF
|
$736.19 Million |
|
Dalata Hotel Group plc
OTCGREY:DLTTF
|
$735.84 Million |
|
XD Inc
PINK:XDNCF
|
$735.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cartesian Growth Corporation II Warrant's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 155,712,246 to 64,304,131, a change of -91,408,115 (-58.7%).
- Net income of 8,206,000 contributed positively to equity growth.
- Share repurchases of 99,613,642 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $8.21 Million | +12.76% |
| Share Repurchases | $99.61 Million | -154.91% |
| Other Changes | $-473.00 | -0.0% |
| Total Change | $- | -58.70% |
Book Value vs Market Value Analysis
This analysis compares Cartesian Growth Corporation II Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 31.47x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 187679.81x to 31.47x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.00 | $138.87 | x |
| 2022-12-31 | $7.71 | $138.87 | x |
| 2023-12-31 | $5.62 | $138.87 | x |
| 2024-12-31 | $4.41 | $138.87 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cartesian Growth Corporation II Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.76%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.32x
- Recent ROE (12.76%) is above the historical average (-11.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -70.08% | 0.00% | 0.00x | 21.79x | $-17.04K |
| 2022 | 2.22% | 0.00% | 0.00x | 1.09x | $-17.24 Million |
| 2023 | 7.35% | 0.00% | 0.00x | 1.12x | $-4.13 Million |
| 2024 | 12.76% | 0.00% | 0.00x | 1.32x | $1.78 Million |
Industry Comparison
This section compares Cartesian Growth Corporation II Warrant's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $-48,301,338
- Average return on equity (ROE) among peers: -1.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cartesian Growth Corporation II Warrant (RENEW) | $64.71 Million | -70.08% | 0.35x | $736.93 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $-22.04K | 0.00% | 0.00x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-468.10 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $-5.96 Million | 0.00% | 0.00x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $-304.95K | 0.00% | 0.00x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-675.40K | 0.00% | 0.00x | $14.42K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $3.99K | -1.81% | 9.57x | $3.15K |